$CORZNeutralLow

DUCHENE TODD M sold $35K of CORZ

DUCHENE TODD M (See remarks) sold 1,300 shares of Core Scientific, Inc./tx (CORZ) at $26.93 on 2026-06-01 under a Rule 10b5-1 trading plan.

6/10
4/10
Low
Neutral
Filed June 3; sale executed June 1 (10b5-1 disclosed after the fact).
Neutral-to-slightly negative (insider selling), tempered by 10b5-1 context.

Insider selling disclosed via Form 4; because it’s 10b5-1, it’s typically less signal than discretionary selling.

Core Scientific officer sold 1,300 shares in an open-market transaction under a pre-arranged 10b5-1 plan on June 1.

Likely limited near-term impact; may slightly pressure sentiment if traders treat it as bearish, but 10b5-1 reduces conviction.

Background

SEC Form 4 reports insider transactions; this one is an officer open-market sale executed under a pre-arranged Rule 10b5-1 plan.

Why it matters

The disclosure updates the insider-trading record but does not introduce new fundamentals or company-specific events beyond the sale details.

Market relevance

Traders may briefly react to insider selling, but 10b5-1 typically lowers the informational content versus discretionary sales.

Market effects

No direct sector read-through; this is a single-company insider transaction disclosure.

None indicated.

None indicated.

Alternative perspectives

Treat the sale as routine 10b5-1 execution rather than a bearish signal; focus on other catalysts (financing, operations, guidance) instead.

Form 4 timing is delayed relative to execution; without additional context (e.g., total insider activity, net selling over time), single-sale interpretation is weak.

Key entities

  • Core Scientific, Inc.

    Subject of the insider transaction disclosure (Form 4) involving an officer sale of CORZ shares.

  • DUCHENE TODD M

    Officer who sold 1,300 CORZ shares at $26.9285 on 2026-06-01 under a 10b5-1 plan.

Related articles

$CORZMedAI 9/10

BTIG Raises Price Target on Core Scientific (CORZ) Following Power Capacity Expansion

BTIG raised its price target on Core Scientific (CORZ) to $33 from $23 and kept a Buy rating after the company said it has about 1.2 GW of approved power capacity for 2024. Core Scientific also opened a 430 MW facility in Texas, bringing Dallas-area capacity to ~825 MW. Separately, Needham lifted its target to $29 after Q1 revenue of $115.2M beat its $106.9M forecast and Core Scientific agreed to acquire Polaris DS (440 MW contracted).

$CORZLow

Core Scientific, Inc. (CORZ): Leopold Aschenbrenner Trims Holding

The article discusses AI and robotics investment themes, citing remarks from Jeff Bezos, Amazon CEO Andy Jassy, and Elon Musk about large future AI/robotics markets. It also claims Insider Monkey’s co-founder Inan Dogan has a 16.5% annual stock-pick return since 2017 and highlights Core Scientific (CORZ), alleging management cut $100 million in waste to refocus on high-margin growth. It promotes paid newsletter offers and “up to 400% upside” claims.

$WULFMed

Bitcoin News Today: Is Mining Dying as TeraWulf Abandons Miners

The 2024 Bitcoin halving cut block rewards from 6.25 BTC to 3.125 BTC, reducing miners’ revenue while electricity costs stayed the same, according to the article. TeraWulf is described as shifting away from mining toward AI hosting, where contract-based revenue per megawatt is more stable. Core Scientific also cited a deal with CoreWeave for AI hosting capacity.

$CORZMedAI 8/10

Jefferies Sees Core Scientific (CORZ) Well Positioned for AI Infrastructure Demand Growth

Jefferies raised its Core Scientific (CORZ) price target to $37 from $24 and kept a Buy rating, citing strong AI data-center demand and power availability as the main constraint. It said success depends on tenant credit quality, durable locations, and execution, noting Core Scientific’s early shift from Bitcoin mining to CoreWeave leases. BTIG also raised its target to $33 from $23, citing progress adding 1.2 GW of approved power capacity.